Search research articles
Contact Us
Filters
Showing results (231-240 of 418) with videos related to
Page
of 42
Sort By:
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
Plos One
|
October 14, 2015
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.
European Urology
|
March 12, 2021
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
Andres F Correa, Opeyemi A Jegede, Naomi B Haas, et al.
Molecular Cancer Therapeutics
|
November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Discovery
|
March 27, 2012
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib
Ryan B Corcoran, Hiromichi Ebi, Alexa B Turke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel
Keith T Flaherty, Joan Schiller, Lynn M Schuchter, et al.
Cancer Immunology Research
|
November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
The Journal of Experimental Medicine
|
April 29, 2017
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Helen L Young, Emily J Rowling, Mattia Bugatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2024
Improving Collection and Analysis of Overall Survival Data
Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2019
Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G<sub>4</sub> Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial
Xinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Page
of 42
Search research articles
Search
Showing results (231-240 of 418) with videos related to
Sort By:
Page
of 42
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
Plos One
|
October 14, 2015
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
Adam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.
European Urology
|
March 12, 2021
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
Andres F Correa, Opeyemi A Jegede, Naomi B Haas, et al.
Molecular Cancer Therapeutics
|
November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Discovery
|
March 27, 2012
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib
Ryan B Corcoran, Hiromichi Ebi, Alexa B Turke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2008
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel
Keith T Flaherty, Joan Schiller, Lynn M Schuchter, et al.
Cancer Immunology Research
|
November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission
Kenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
The Journal of Experimental Medicine
|
April 29, 2017
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Helen L Young, Emily J Rowling, Mattia Bugatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2024
Improving Collection and Analysis of Overall Survival Data
Lisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2019
Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G<sub>4</sub> Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial
Xinan Sheng, Xieqiao Yan, Zhihong Chi, et al.
Page
of 42